Adolescent Pharmacological Treatment of DSM-5 Eating Disorders

Adolescent Pharmacological Treatment of DSM-5 Eating Disorders Paper details The paper should include at least two studied treatments for the disorder in question (e.g., lithium or carbamazepine in the treatment of bipolar depression, typical or atypical agents in the treatment of psychosis, tricyclic antidepressants or SRIs in the treatment of depression, methylphenidate or pemoline in the treatment of ADHD). The strength of the evidence supporting each treatment should be discussed, along with basic parameters of treatment. The incorporation of non-pharmacological strategies into treatment (e.g., psychosocial treatments for). Presentation should focus on the neurological underpinnings of the disorder. It should include areas of the brain that are affected, the interplay of different neurological systems including transmission of neurochemicals. The presentation should include how, why, and the effectiveness of using psychotropic medications to treat the disorder.